Bordetella Bronchiseptica Intranasal Vaccine

This treatment applies to the following species:

Swine

Company: MVP Labs.

Bordetella bronchiseptica Vaccine (Avirulent Live Culture)

U.S. Vet. Lic. No.: 301

Active Ingredient(s): The vaccine contains cultures of avirulent live Bordetella bronchiseptica.

Bordetella Bronchiseptica Intranasal Vaccine Indications

For use as an aid in the prevention of respiratory disease associated with virulent Bordetella bronchiseptica in swine.

Dosage and Administration

Shake well before and occasionally during use. Administer 1/2 mL into each nostril of piglets within 24 hours of birth.

Precaution(s): Store at 35°-45°F (2°-7°C). Do not freeze.

Caution(s): Use the entire contents when first opened. Burn the container and any unused contents after use.

For veterinary use only.

Warning(s): Do not use within 21 days before slaughter.

Presentation: 30 mL (30 dose) and 100 mL (100 dose) vials.

CPN: 11120000

PHIBRO ANIMAL HEALTH COMPANY
Distributed by PHIBRO ANIMAL HEALTH CORPORATION
GLENPOINTE CENTRE EAST, 300 FRANK W. BURR BOULEVARD, SUITE #21, TEANECK, NJ, 07666

Telephone:		201-329-7300
Customer Service:		888-403-0074
Fax:		201-329-7070
Website:		www.pahc.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.